Base to Base biotech podcast 23: Digitalisation in labs, and are fibroblasts the future of regenerative medicine?

This week, we have a wide-ranging conversation with Anna Codina, senior director strategy and business development at SciY (part of Bruker), as we discuss artificial intelligence, and digitalisation, and the effect on labs. We also chat with Fibrobiologics’ CEO Pete O'Heeron about fibroblast spheroid technology.

Interview times:

03:49 FibroBiologics

21:26 SciY

SciY on the path to digitalisation

This week, we have a wide-ranging conversation with Anna Codina, senior director strategy and business development at SciY (part of Bruker), as we discuss artificial intelligence, and digitalisation, and the effect on labs.

SciY